Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.2
Condensed Consolidated Balance Sheets - USD ($)
Apr. 30, 2019
Jul. 31, 2018
Current assets    
Cash and cash equivalents $ 22,257,659 $ 3,803,627
Prepaid expenses and other current assets 2,286,271 1,643,749
Investment securities 998,938 23,174,447
Total Current Assets 25,542,868 28,621,823
Property and equipment, net 1,092,109 1,265,662
Other long-term assets 357,533 358,987
Total Assets 26,992,510 30,246,472
Current liabilities    
Accounts payable and accrued liabilities 3,836,280 4,778,892
Accrued compensation and related 1,061,075 1,070,744
Note payable 165,768
Total Current Liabilities 5,063,123 5,849,636
Other long-term liabilities 752,393 1,472,630
Total Liabilities 5,815,516 7,322,266
Commitments and Contingencies (Note 9)
Stockholders' Equity    
Common stock authorized - 16,000,000 common shares with a par value of $0.0001, common stock issued and outstanding - 7,111,258 and 5,351,162 common shares as of April 30, 2019 and July 31, 2018, respectively 711 535
Additional paid-in capital 166,751,031 145,749,189
Warrants issued and outstanding - 892,890 and 895,805 warrants as of April 30, 2019 and July 31, 2018, respectively 11,171,166 11,271,327
Accumulated other comprehensive income (loss) 108,651 (16,024)
Accumulated deficit (156,854,565) (134,080,821)
Total Stockholders' Equity 21,176,994 22,924,206
Total Liabilities and Stockholders' Equity $ 26,992,510 $ 30,246,472